You are here

  • Home
  • Archive
  • Volume 43, Issue 4
  • Authors' response to ’Comment on ’Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial' '

Article info

Article menu
Download PDFPDF
Letter to the editor
Authors' response to ’Comment on ’Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial' '

Authors

  • G Justus Hofmeyr Effective Care Research Unit, Eastern Cape, Department of Health, Universities of the Witwatersrand, Walter Sisulu and Fort Hare, East London, South Africa; justhof@gmail.com PubMed articlesGoogle scholar articles
  • Theresa Anne Lawrie Effective Care Research Unit, Eastern Cape, Department of Health, Universities of the Witwatersrand, Walter Sisulu and Fort Hare, East London, South Africa Royal United Hospital, Bath, UK; tess@lawrie.com PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Theresa Anne Lawrie; tess{at}lawrie.com
View Full Text

Citation

Hofmeyr GJ, Lawrie TA
Authors' response to ’Comment on ’Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial' '
Journal of Family Planning and Reproductive Health Care 2017;43:344.

Publication history

  • Received July 10, 2017
  • Accepted July 11, 2017
  • First published October 10, 2017.
Online issue publication 
November 26, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.